Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Market Climber Inc., operating as MCI Capital Markets, is a specialized capital markets advisory firm that provides investor relations and strategic communication services primarily to the life sciences, biotechnology, and medtech sectors. Headquartered in Calgary, the firm assists management teams in navigating complex financial challenges, including activist investor defense and valuation turnarounds. In March 2026, the company announced a significant partnership with AxialBridge to provide an integrated platform that combines clinical and regulatory de-risking with capital access for emerging healthcare companies. Market Climber has supported over $5.7 billion in corporate actions across North American exchanges, focusing on making complex scientific narratives investable for the broader market. The firm's expertise bridges the gap between technical validation and institutional capital for companies transitioning through regulatory approval.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Market Climber.